STANDARD BIOTOOLS INC. — Director's Dealing 2011

Feb 18, 2011

SEC Form 4/A — Form 4/A

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2011-02-15

Reporting Person: COLELLA SAMUEL D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-15	Common Stock	C	2065	—	Acquired	2065	Indirect
2011-02-15	Common Stock	C	7297	—	Acquired	9362	Indirect
2011-02-15	Common Stock	C	6401	—	Acquired	15763	Indirect
2011-02-15	Common Stock	C	1769	—	Acquired	17532	Indirect
2011-02-15	Common Stock	C	5185	—	Acquired	22717	Indirect
2011-02-15	Common Stock	C	29190	—	Acquired	51907	Indirect
2011-02-15	Common Stock	C	13442	—	Acquired	65349	Indirect
2011-02-15	Common Stock	C	3715	—	Acquired	69064	Indirect
2011-02-15	Common Stock	C	2092	—	Acquired	71156	Indirect
2011-02-15	Common Stock	C	10425	—	Acquired	81581	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-15	Series E Preferred Stock	$	C	2065	Disposed		Common Stock (2065)	Indirect
2011-02-15	Series B Preferred Stock	$	C	7297	Disposed		Common Stock (7297)	Indirect
2011-02-15	Series C Preferred Stock	$	C	6401	Disposed		Common Stock (6401)	Indirect
2011-02-15	Series D Preferred Stock	$	C	1769	Disposed		Common Stock (1769)	Indirect
2011-02-15	Series E Preferred Stock	$	C	5185	Disposed		Common Stock (5185)	Indirect
2011-02-15	Series B Preferred Stock	$	C	29190	Disposed		Common Stock (29190)	Indirect
2011-02-15	Series C Preferred Stock	$	C	13442	Disposed		Common Stock (13442)	Indirect
2011-02-15	Series D Preferred Stock	$	C	3715	Disposed		Common Stock (3715)	Indirect
2011-02-15	Series E Preferred Stock	$	C	2092	Disposed		Common Stock (2092)	Indirect
2011-02-15	Series B Preferred Stock	$	C	10425	Disposed		Common Stock (10425)	Indirect

Footnotes

F1: Represents shares of Common Stock issued upon conversion of shares of Series E Preferred Stock on a 1-for 1.300053676865 basis.

F2: Not applicable.

F3: Versant Affiliates Fund I-A, L.P., is the record holder of the securities reported.

F4: Voting and investment power over the shares directly held by Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., Versant Affiliates Fund I-B, L.P., and Versant Side Fund I, L.P., is held by Versant Ventures I, LLC, their sole General Partner, Samuel D. Colella, the reporting person is a Managing Member of Versant Ventures I, LLC but he disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The individual Managing Members of Versant Ventures I, LLC are Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, and Rebecca B. Robertson, all of whom share voting and dispositive control. Each respective individual General Partner disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest therein.

F5: Represents shares of Common Stock issued upon the conversion of shares of Series B Preferred Stock, Series C Preferred Stock or Series D Preferred Stock on a 1-for-1 basis.

F6: Versant Affiliates Fund I-B, L.P. is the record holder of the securities reported.

F7: Versant Side Fund I, L.P., is the record holder of the securities reported.

F8: Each share of Series E Preferred Stock automatically converted into 1.300053676865 share of Common Stock on February 15, 2011, the closing date of the Issuer's initial public offering (the "Closing") and has no expiration date.

F9: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into one share of Common Stock on the Closing Date and has no expiration date.